Gorio A, Donadoni M L, Di Giulio A M
Department of Medical Pharmacology, University of Milano, Italy.
J Neurosci Res. 1995 Feb 15;40(3):420-6. doi: 10.1002/jnr.490400318.
Endogenous ADP-ribosylation of proteins was studied in retina crude extract, membrane and cytosolic fractions of control and diabetic rats. ADP-ribosyltransferase activity is present in all cellular fractions, but protein ADP-ribosylation is reduced in diabetic rat retina. At least 6 proteins are labelled in the crude extract fraction and a similar number in the membrane preparation of control animals. In these preparations from diabetic retina, only two bands were labelled, the 85 K and 36 K for the crude extract, and the 97 K and 39 K for membranes. Labelling of 36 K and 39 K proteins was much less than in controls. In the cytosolic preparations of controls, two proteins of 85 K and 39 K are ADP-ribosylated, while in diabetic rat retina cytosol, only the 85 K is labelled. Treatment of diabetic rats with insulin normalized plasma glucose levels and prevented the alterations of the extent of ADP-ribosylation for the 38 K cytosolic, 39 K membrane and 36 K crude extracts proteins, but it failed to affect the other bands. These results suggest a hyperactivity of endogenous ADP-ribosylases in diabetic rat retina, so that the protein sites for ADP-ribosylation are no longer available. Since insulin treatment prevents the onset of neuropathy and of retinal G protein impairment (Abbracchio et al., J Neurosci Res 29:196-220, 1991) in diabetic rats and, in this study, normalizes ADP-ribosylation of 39 K, 38 K and 36 K proteins, we suggest that the abnormal endogenous ADP-ribosylation of these proteins might play a role in the onset of diabetic neuropathy.
在对照大鼠和糖尿病大鼠的视网膜粗提物、膜组分和胞质组分中研究了蛋白质的内源性ADP-核糖基化。ADP-核糖基转移酶活性存在于所有细胞组分中,但糖尿病大鼠视网膜中的蛋白质ADP-核糖基化减少。在粗提物组分中至少有6种蛋白质被标记,对照动物的膜制剂中也有类似数量的蛋白质被标记。在糖尿病视网膜的这些制剂中,仅两条带被标记,粗提物中的85K和36K,以及膜中的97K和39K。36K和39K蛋白质的标记比对照少得多。在对照的胞质制剂中,85K和39K的两种蛋白质被ADP-核糖基化,而在糖尿病大鼠视网膜胞质溶胶中,仅85K被标记。用胰岛素治疗糖尿病大鼠可使血糖水平正常化,并防止38K胞质、39K膜和36K粗提物蛋白质的ADP-核糖基化程度改变,但未能影响其他条带。这些结果表明糖尿病大鼠视网膜中内源性ADP-核糖基酶活性过高,以至于不再有可供ADP-核糖基化的蛋白质位点。由于胰岛素治疗可预防糖尿病大鼠神经病变和视网膜G蛋白损伤的发生(Abbracchio等人,《神经科学研究杂志》29:196 - 220,1991),并且在本研究中,可使39K、38K和36K蛋白质的ADP-核糖基化正常化,我们认为这些蛋白质异常的内源性ADP-核糖基化可能在糖尿病神经病变的发生中起作用。